Related Experiment Video
Updated: May 20, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Cortical thinning in amphetamine-type stimulant users
P Koester1, M Tittgemeyer, D Wagner
1Department of Psychiatry and Psychotherapy, University Hospital of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Abstract:
Accumulating evidence supports the hypothesis of ecstasy and amphetamine exhibiting neurotoxic properties in human recreational users. The extent and exact location of neuronal degeneration might also be associated with a specific profile of cognitive deterioration described in polydrug users. Voxel-based morphometry and cortical thickness analyses constantly gain attention for answering the question of associated neurological sequelae. We aimed to evaluate the integrity of cortical and subcortical structures in three groups that differ in the consumption of amphetamine-type stimulants. Cortical thickness, cortical grey matter volume and the shape of supposedly vulnerable subcortical structures were compared between 20 experienced users, 42 users with little exposure to these substances and 16 drug- naïve controls. Cortical thinning in experienced users compared to drug-naïve controls and low-exposure users was observed in medio-frontal regions. Effects of ecstasy and amphetamine on cortical volume were similar to those of cortical thickness, with volume reductions primarily in frontal, but also in occipital and parietal regions of low exposure and experienced users. These effects were differently lateralized for the different comparisons. The investigation of subcortical structures revealed non-significant bilateral shape differences in the hippocampi. Our data support the hypothesis that massive recreational amphetamine-type stimulant polydrug use is associated with a thinning of cortical grey matter. Disrupted neuronal integrity in frontal regions does fit well into models of addiction and the cognitive deterioration in amphetamine-type stimulant polydrug users. The exact neurotoxic mechanisms of polydrug ecstasy and amphetamine use, however, remain speculative.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Stimulants: Psychedelic Agents

